BR0008914A - Método para a diagnose e tratamento do carcinoma, sua preparação e uso da hipericina - Google Patents

Método para a diagnose e tratamento do carcinoma, sua preparação e uso da hipericina

Info

Publication number
BR0008914A
BR0008914A BR0008914-1A BR0008914A BR0008914A BR 0008914 A BR0008914 A BR 0008914A BR 0008914 A BR0008914 A BR 0008914A BR 0008914 A BR0008914 A BR 0008914A
Authority
BR
Brazil
Prior art keywords
carcinoma
hypericin
diagnosis
preparation
treatment
Prior art date
Application number
BR0008914-1A
Other languages
English (en)
Inventor
Peter Alfred Maria De Witte
Etienne Jean Pierre M Waelkens
Marie-Ange D Hallewin
Luc Baert
Original Assignee
Leuven K U Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leuven K U Res & Dev filed Critical Leuven K U Res & Dev
Publication of BR0008914A publication Critical patent/BR0008914A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MéTODO PARA A DIAGNOSE E TRATAMENTO DO CARCINOMA, SUA PREPARAçãO E USO DA HIPERICINA". A presente invenção se refere ao uso da hipericina ou análogos ou derivados dela provenientes para a preparação de uma composição diagnóstica para a diagnose do carcinoma, mais em particular do carcinoma que se origina a partir do urotélio, especialmente o carcinoma de bexiga. Adicionalmente a invenção proporciona um fluido de instilação compreendendo hipericina ou análogos ou derivados dela provenientes para uso em um método para a diagnose de tais carcinomas.
BR0008914-1A 1999-03-11 2000-03-10 Método para a diagnose e tratamento do carcinoma, sua preparação e uso da hipericina BR0008914A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99200747A EP1040825A1 (en) 1999-03-11 1999-03-11 Means for diagnosing bladder carcinoma
PCT/EP2000/002193 WO2000053170A1 (en) 1999-03-11 2000-03-10 Means for diagnosing and treating carcinoma

Publications (1)

Publication Number Publication Date
BR0008914A true BR0008914A (pt) 2002-01-29

Family

ID=8239974

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008914-1A BR0008914A (pt) 1999-03-11 2000-03-10 Método para a diagnose e tratamento do carcinoma, sua preparação e uso da hipericina

Country Status (7)

Country Link
EP (2) EP1040825A1 (pt)
JP (1) JP2002538201A (pt)
KR (1) KR20020008124A (pt)
AU (1) AU3429300A (pt)
BR (1) BR0008914A (pt)
WO (1) WO2000053170A1 (pt)
ZA (1) ZA200107345B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100450523B1 (ko) * 2002-03-13 2004-10-01 이종근 애완견용 신발 주걱
GB0723124D0 (en) 2007-11-26 2008-01-02 Univ Leuven Kath Targeted radiotherapy
AT508680B1 (de) * 2009-05-19 2011-03-15 Onkotec Gmbh Verfahren zur qualitativen und/oder quantitativen bestimmung von tumorzellen
DE102014204138A1 (de) * 2014-03-06 2015-09-24 Briu Gmbh Pharmazeutische Formulierung, Verfahren zur Herstellung der pharmazeutischen Formulierung und Infusionslösung sowie deren Verwendung als Medizinprodukt und/oder als Medikament
US9629932B2 (en) * 2015-09-28 2017-04-25 Sanochemia Pharmazeutika Ag Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method for the production and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4228106A1 (de) * 1992-08-24 1994-03-03 Medac Klinische Spezialpraep Verwendung von £-Aminolävulinsäure zur Herstellung eines topischen Arzneimittels zur integralen Diagnose und/oder Therapie von Tumoren in Hohlorganen
AU5959994A (en) * 1992-12-23 1994-07-19 Iowa State University Research Foundation Inc. Molecular flashlight
US6576784B1 (en) * 1993-05-27 2003-06-10 Yeda Research And Development Co. Ltd. Antiviral agents
JP3394566B2 (ja) * 1993-07-16 2003-04-07 富士写真フイルム株式会社 癌の光化学療法用医薬組成物
IT1275571B (it) * 1995-07-19 1997-08-07 Consiglio Nazionale Ricerche Substrati fluorogenici suscettibili di fotoattivazione previa trasformazione per via enzimatica atti alla diagnosi ed alla terapia fotodinamica dei tumori
WO1997019705A1 (en) * 1995-12-01 1997-06-05 Elmaleh David R Stereoisomers of fatty acid analogs for diagnostic imaging

Also Published As

Publication number Publication date
KR20020008124A (ko) 2002-01-29
EP1162963A1 (en) 2001-12-19
ZA200107345B (en) 2002-11-27
EP1040825A1 (en) 2000-10-04
JP2002538201A (ja) 2002-11-12
AU3429300A (en) 2000-09-28
WO2000053170A1 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
DE69021214T2 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
NO20073429L (no) Anvendelse av et antistoff mot interleukin-6-reseptor for fremstilling av et farmasoytisk preparat
ES2062437T3 (es) Nueva forma farmaceutica porosa y su preparacion.
ATE388167T1 (de) Menschlicher antikörper gegen gangliosid gd3 für die transplantationskomplementarität bestimmente regionund derivate des antikörpers gegen das gangliosid gd3
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
YU54499A (sh) Farmaceutski preparat za primenu na mukozu
WO2003048333A3 (en) Endorepellin compositions and methods for inhibiting angiogenesis
ES2138729T3 (es) Metodos de diagnostico de la preeclampsia.
ES2134768T3 (es) Composicion farmaceutica que comprende un fosfoazucar.
BR0011928A (pt) Composto, composição farmacêutica, uso de, um composto e métodos para o tratamento de complicações diabéticas, para o tratamento ou a prevenção do desenvolvimento de condições de doença associadas com velocidade de condução neuronial prejudicada e de neuropatia diabética
ES2189961T3 (es) Un ensayo de diagnostico para la esquizofrenia que emplea niacina.
BR0008914A (pt) Método para a diagnose e tratamento do carcinoma, sua preparação e uso da hipericina
NO934794L (no) Preparater av iodfenoksyalkaner og iodfenyletere for visualisering av mage/tarmkanaler
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
BR9812780A (pt) 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio
BRPI0116865B8 (pt) composição compreendendo bisfosfonatos para prevenção e/ou tratamento de doenças metabólicas dos ossos, processo para preparar tal composição e uso desta
BR0215389A (pt) Agente preventivo ou terapêutico para distúrbio urinário, método para prevenir ou tratar distúrbio urinário, uso de um composto, composto, pró-droga, processo para preparar o composto, medicamento, e, método para triar um composto
SE7910554L (sv) Disulfidforeningar
BR0014687A (pt) Compostos de taxano pentacìclico
KR970061248A (ko) 알츠하이머병 치료용 1, 1, 2-트리페닐부트-1-엔 유도체
BR0111636A (pt) Dispositivo de vasoregulação
BR9908021A (pt) Artigo absorvente que inclui uma camada componente apresentando um obstáculo ao fluxo de fluido através da camada
BR0212259A (pt) Formulação de liberação controlada de claritromicina ou tinidazol
BRPI0412224A (pt) uso de cloreto do sódio, cloreto de sódio, emplastro, dispositivo, preparado e método de manufatura de um medicamento

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired